[Psoriasis and anxiety: marked improvement after anxiolytic therapy].
Figueroa Quintana
A
A
Díez Suárez
A
A
España Alonso
A
A
Soutullo Esperón
C
C
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D002675:Child, Preschool; D003009:Clorazepate Dipotassium / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology; D012074:Remission Induction
D014151:Anti-Anxiety Agents; D003009:Clorazepate Dipotassium